[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Benef](https://github.com/mm80843/T3.5/tree/main/docs/Benef/index.md) >> Individual ID:PBN__Benef_504 

# __Averted/delayed infections__

## Articles mentionning this Benefit

* [The effect of large-scale anti-contagion policies on the COVID-19 pandemic](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_103.md)

## Category to which it belongs

* [Effective control and elimination of infectious pathogens to prevent disease transmission and reduce the overall risk of infection.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_1.md)

## Description of actual returns pertaining to this benefit

* [Private investors investing in these policies can benefit from a lower burden on healthcare systems, reduced mortality rates, and a more robust and resilient economy in the long run.](https://github.com/mm80843/T3.5/blob/pages/BenefReturn/PBN__BenefReturn_550.md)

## Name of the Benefit

The implementation of anti-contagion policies has resulted in a significant reduction in the number of COVID-19 infections compared to a scenario where no policies were implemented.

## Risks which can benefit from this action

* [Implementation of anti-contagion policies](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_516.md)

## Stakeholders benefitting from this Benefit

* [General population](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_9.md)

